IP : Oxford Nanopore Technologies and SeqOne partner to support interpretation of nanopore sequencing in clinical use -March 12, 2024 at 10:46 am EDT
11 Mar 2024 A new partnership will provide end-to-end solutions from sample to report for whole genome nanopore sequencing reads at scale in future clinical...
France General Gordon Sanghera Laurent Mesnard Oxford Nanopore Seqone Diagai Research Partnership Program
Source: marketscreener.com